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Abstract Orexin A (OXA) is an excitatory hypothalamic
neurotransmitter and ligand for Orexin Receptor-1 (OR1),
isolated from a small group of hypothalamic neurons. OXA
orchestrates different brain functions, and at the cognitive
level some of the effects of insufﬁciency of OXA are well-
known, for example in Parkinson’s disease. It is widely
assumed that deteriorated cognitive processes are related to
impaired network connectivity. However, little is known
about the effects of OXA in network connectivity and
synaptogenesis. Therefore, to obtain insight into this
problem we designed experiments with two groups of
networks of dissociated cortical neurons: one group incu-
bated in a plain medium and another chronically treated
with OXA. After 1, 2, 3 or 4 weeks in vitro we applied
immunocytochemistry for detection of OXA, OR1, and
synaptic marker synaptophysin. Shortly after plating,
91 ± 8% of the neurons cultivated in a plain medium
expressed OXA-immunoreactivity, which does normally
not occur in vivo indicating that neurons may change their
phenotype under non-natural culture conditions to develop
synaptically coupled networks. The fraction of orexinergic
neurons decreased to 33 ± 21% after 4 weeks in vitro.
OXA expression was highest in the ﬁrst week of network
formation, the period of maximum synaptogenesis, and
then decreased and stabilized in the weeks thereafter. Our
hypothesis that OXA plays a role in the network devel-
opment as a synaptogenic factor was supported by higher
levels, earlier onset, and sustained increase of synapto-
physin expression in experiments with chronic OXA
application to the culture medium.
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Introduction
Orexin A (OXA) is produced by a small group of neurons
speciﬁcally located within and around the lateral hypothal-
amus (LH) (de Lecea et al. 1998). Like OXB, OXA is a
neuropeptide encoded by mRNA which accumulates pri-
marily after the third postnatal week (Gautvik et al. 1996).
OXA is a 33-amino acid peptide, the sequence of which is
identical in human, rat, mouse, and bovine (Sakurai et al.
1998). Experiments with synaptically coupled rat hypotha-
lamic neurons, demonstrate that Orexin acts as an excitatory
neurotransmitter with two speciﬁc receptors (de Lecea et al.
1998), Orexin Receptor-1 (OR1) and Orexin Receptor-2
(OR2), which belong to the G-protein coupled receptor
superfamily(Sakuraietal.1998).Thesereceptorsshare64%
identity in their amino acid sequence and exhibit marked
differential distribution. OXA is a selective ligand for OR1.
Incontrasttoorexinergicneurons,thepresenceofORsisnot
restricted to the hypothalamus. Both OR types have a high
level of expression in multiple brain regions (Trivedi et al.
1998) and thus orexins may orchestrate a large number of
processes in the nervous system (Fadel et al. 2002).
It is widely assumed that deteriorated cognitive pro-
cesses are related to impaired network connectivity and
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that lead to deteriorated cognitive abilities have been
related to OXA deﬁciency. Both the number of orexinergic
neurons in the hypothalamus and the levels of orexin in the
cerebrospinal ﬂuid are reduced by 72% in the end-stage in
a mouse model of Huntington’s disease (Peterse ´n et al.
2005). Recent studies in Parkinson’s patients found a 40%
lower OXA concentration in the frontal cortex and a 25%
reduction in the cerebrospinal ﬂuid (Fronczek et al. 2007).
These ﬁndings suggest that orexin may inﬂuence network
connectivity and activity.
Experiments in vivo (Peever et al. 2003) and in vitro
with acute application of the transmitter on organotypic
brain slices (Horvath et al. 1999) or dissociated neuronal
cultures (Stoyanova et al. 2011) indicated that OXA has an
excitatory effect on network activity. However, the effects
of OXA on cortical development remain unclear, in par-
ticular the effect on synaptogenesis.
It has been shown that synaptic formation responds to
various inputs. For instance, Horvath and Gao (2005)
demonstrated synaptic re-organization in orexinergic neu-
rons in vivo after glucose deﬁciency, but detailed data
about the synaptogenesis is not easy to acquire in vivo.
Furthermore, it is very difﬁcult to quantify orexinergic
input to the cortex in vivo. Therefore, we used cultures of
dissociated cortical neurons to investigate the effects of
OXA on synaptogenesis in a controlled study.
Dissociated cortical neurons have been shown to form
networks and to become spontaneously active after
approximately a week (Van Pelt et al. 2004; Chiappalone
et al. 2006). We designed experiments with two groups of
networks: one incubated in plain medium, and the other in
medium chronically supplemented with OXA. Immuno-
staining for OR1 was applied in order to determine at what
developmental stage the receptor is expressed and neurons
could react to the OXA application. To quantify the
alterations in network formation we combined it with
immunocytochemistry for detection of OXA and synaptic
marker synaptophysin during the ﬁrst 4 weeks of devel-
opment in vitro.
Materials and Methods
Dissociated Cell Cultures
Newborn Wistar rats were anesthetized with ether and
decapitated. The brains were removed and placed in RPMI-
medium. The meninges were removed; the cortices were
dissociated and collected in chemically deﬁned R12 culture
medium (Romijn et al. 1984) with trypsin for chemical
dissociation. After the trypsin, 150 ll of soybean trypsin
inhibitor and 125 ll of DNAse I (20.000 units, Life
Technology) were added, followed by mechanical disso-
ciation of the neurons. The suspension was centrifuged at
1200 rpm for 5 min; the pellet was plated on glass cover
slips pre-coated with 20 mg/ml poly-ethylene-imine
(Fluka, Buchs, Switzerland), at a density of approximately
3000 cells/mm
2. They were allowed to attach for 2 h at
37C and 5% CO2 in air and kept in R12 medium opti-
mized with 50 ng/ml nerve growth factor (Invitrogen,
Carlsbad, CA). Medium was serum-free to suppress glial
cell proliferation and keep their concentration lower than
5% (Romijn et al. 1984). It was renewed every 2–3 days.
For assessment of the effect of OXA on synaptogenesis
2 lM OXA was added to the medium. We use this con-
centration because it has been shown that it produces
measurable changes in neuronal activity (Horvath et al.
1999). Cultures were ﬁxed in 4% paraformaldehyde in
0.1 M phosphate buffered saline (PBS), pH 7.4 after 1, 4, 7,
14 or 21 DIV, and processed for immuno-detection of
OXA, OR1, or synaptophysin. For identiﬁcation of the
cellular type we applied speciﬁc markers, i.e., anti-Micro-
tubule Associated Protein (MAP2) antibody as a neuronal
marker and anti-Glial Fibrillary Acidic Protein (GFAP)
antibody, a marker for glial cells.
Animals and Tissue Preparation
Adult Wistar rats (250–359 g body weight) were used as a
positivecontrolfortestingspeciﬁcityofanti-OXAantibody.
Allhousing facilitiesand procedures used were approved by
the Animal Care and Use Committee of the University of
Twente, and were carried out in accordance with the Euro-
peanCommunitiesCouncilDirective of24November1986.
The rats were anesthetized and perfused with 4% parafor-
maldehyde in 0.1 M PBS (pH 7.4). The brains were
removed, postﬁxed by immersion in the same ﬁxative for
24 hat4Candcryoprotectedin25%sucroseinPBSat4C.
They were embedded in TissueTek OCT compound (Miles
Inc., Elkhart, NI, USA), frozen and 30 lm thick sections
were cut in a cryostat at -20C. After rinsing in 0.1 M PBS,
free-ﬂoating slices selected from -0.92 to -5.20 mm (from
Bregma), i.e., where the orexinergic neurons are localized,
were processed immunocytochemically.
Immunocytochemistry
The immunostaining was performed according to the ABC
(avidin–biotin–horseradish peroxidase) method (Hsu et al.
1981). Brieﬂy, the endogenous peroxidase was inactivated
with hydrogen peroxide (0.3% in methanol/PBS for
30 min), and the background was blocked with 5% normal
goat serum (NGS) and 1% bovine serum albumin (BSA) in
0.5% Triton X-100. Appropriate rinsing in PBS followed
these and subsequent procedures. Incubation in the primary
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123antibodies (rabbit anti-Orexin A IgG, Calbiochem, Merck
Chemicals, Nottingham, dilution 1:500; goat anti-OR1,
1:200, AbD Serotec, Oxford, UK; mouse anti-synapto-
physin, 1:800, Abcam, Cambridge, UK; rabbit anti-MAP2,
1:200, and rabbit anti-GFAP, 1:750, both Abcam) was for
20 h at room temperature (RT), followed by treatment for
2 h with biotinilated secondary antibodies (goat anti-rabbit,
donkey anti-mouse, donkey anti-goat IgG (1:500); Jackson
ImmunoResearch, West Grove, PA, USA). After rinsing,
the cell cultures and brain slices were incubated for 1 h in
ABC complex (Vector Labs, Burlingame, CA, USA,
6.25 ll/ml of each compound in PBS). The peroxidase
activity was visualized using 2.4% SG substrate kit (Vec-
tor) in PBS for 5 min at room temperature. The specimens
were counterstained with 0.5% Neutral red (Sigma, St.
Louis, MO, USA). Finally, the cultures and the brain slices
were dehydrated in alcohol, cleared in xylene and covers-
lipped with Entellan (Merck, Darmstadt, Germany).
Negative controls included incubation at 4C for 24 h
after antigen–antibody preabsorption with the native anti-
gen OXA (Calbiochem, Merck Chemicals, Nottingham),
and replacement of the other primary antibodies with
normal serum.
Data Analysis and Photomicrograph Production
Seven culturing experiments were made; eight to ten brains
were used for each experiment. The dissociated cells were
plated on 120 coverslips per experiment. We semi quanti-
tatively graded the level of OXA expression in the neurons
according to Ljungdahl et al. (1978), using the following
four-point intensity scale: (-) background intensity of
staining; (?) low intensity; (??) moderate intensity;
(???) high intensity. The images were generated through
109,2 0 9,4 0 9, and 609 objectives and the cultures and
brain slices were photographed with a Nikon DS-Fi1 digital
camera linkedtoaNikonEclipse50imicroscope.Alldigital
imageswerematchedforbrightnessinAdobePhotoshop7.0
software. Cell counts for OXA expression were performed
onﬁverandomlychosencoverslipsperagegroup.Statistical
computations were performed using the StatView package
for Windows, v 4.53 (Abacus Concepts Inc., Berkeley,
California,USA).Theanalysisshowedthatdatadistribution
isnotnormal,thereforeweusedthenon-parametricalMann–
WhitneyandKruskal–Wallistestsforstatisticalcomparison.
For quantitative analysis of synaptic marker expression we
counted the number of granules of reaction product after the
synaptophysin staining. In each culture we calculated the
granuledensityunderahighmagniﬁcationatsevendifferent
randomly chosen locations. We used Nikon NIS-Elements
software, and obtained estimates of the mean densities per
lm
2 and standard deviations. We used two-way ANOVA to
assess the statistical signiﬁcance of density differences.
Known sources of variation were control vs. OXA treated
cultures and culture age. All data were presented as the
mean ± SD (standard deviation). A P value smaller than
0.05 was considered statistically signiﬁcant.
Results
Speciﬁcity
The immunoreactivity was readily discernible by the pres-
ence of a dark-gray immunoreactive product. Neuronal
structures were considered to be immunopositive when their
staining was stronger than that in the background. In the
brain slices OXA-positive cell bodies were found bilater-
ally, conﬁned to the lateral hypothalamus at the level of the
median eminence (Fig. 1a, b). There were no neurons in the
Fig. 1 Coronal section through the hypothalamus of an adult rat
labeled with OXA antiserum. a Low magniﬁcation showing OXA-
positive neurons distributed bilaterally in the lateral hypothalamus
(dark cells). b Higher magniﬁcation of OXA-positive neurons in the
perifornical area. Fornix (F). Scale bars:( a) 200 lm; (b)5 0lm
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123brain cortex expressing OXA. We saw no immunoreactivity
for OXA, OR1 or synaptophysin in the controls after pre-
absorption of the antibody with the antigen or its replace-
ment with normal serum at the same concentration.
Identiﬁcation of Neuronal and Glial Cells
in the Cultures
In order to exclude the opportunity for OXA to be
expressed by glial cells we applied immunostaining for
neuronal and glial markers MAP2 and GFAP, respectively.
In 1-day-old cultures it was hard to morphologically dis-
criminate neurons from glial cells, but immunolabeling for
GFAP indicated a very low fraction of glial cells. After one
or more weeks of culturing, glial cells were well developed
and none of the OXA-labeled cells had their morphology.
In contrast, immunostaining for MAP2 and OXA clearly
showed the same morphology of the labeled cells, i.e., only
neurons were OXA-positive (data not shown).
Expression of OXA-, OR1- and Synaptophysin-
Immunoreactivity
Immunolabeling revealed that 91 ± 8% of the neurons in
1-day-old cultures were OXA-immunoreactive (IR). The
reaction product was not uniformly distributed throughout
the cytoplasm, but was sometimes concentrated in a
restricted area of the perikaryon (Fig. 2a). The size of the
neuronal cell bodies was small and the arborizations were
shorter and thinner.
In cultures grown for 1 week (Fig. 2b), a signiﬁcantly
lower fraction of all neurons (83 ± 13%, P = 0.03) were
OXA-IR. The majority of orexinergic neurons were small,
with ﬁne bipolar or tufted dendrites, but some medium- to
large-sized cells with basket-like morphology were also
observed. The immunoreactivity was evenly distributed
throughout the cell soma, excluding the nucleus.
In two-week-old cultures the proportion of OXA-IR
neurons was 49 ± 18%, signiﬁcantly lower than in 1-day-
and 1-week-old cultures (P\0.0001). The neurons were
already well developed and the orexinergic population
consisted of two well distinguishable types of cells: spindle-
shaped neurons and multipolar, pyramidal neurons. The
intensity of immunostaining varied from (-), mainly in
the large-sized perikarya, to (?), (??), and (???) in the
medium- to small-sized neurons of both multipolar and
bipolar types (Fig. 2c). After 3 weeks’ of growth (Fig. 2d),
theclustersofneuronsbecameverydenseandthepercentage
of OXA-expressing neurons was 32 ± 19%. In 4-week-old
cultures(Fig. 2e)thefractionoforexinergicneuronswasnot
changed signiﬁcantly: 33 ± 21% as summarized in Fig. 2f.
Figure 3 shows the time course of expression of OR1-IR
in cultures between 1 day and 4 weeks in vitro. After 1 day
in vitro, neurons already demonstrated some initial
expression of OR1 peptide (Fig. 3a). After 1 week, the
immunoreactivity was more prominent and expressed in
almost all neurons (Fig. 3b). When neurons were cultured
for two or more weeks, the immunoreaction product was
clearly discernible not only on the perikarya but also along
the neurites (Fig. 3c, d).
Chronic treatment of the cultures with medium supple-
mented with 2 lM OXA resulted in signiﬁcant changes in
synaptic development. As early as 4 days after OXA
application, the neurons already showed some expression
of synaptophysin (Fig. 4a), while the control cultures were
immunonegative (Fig. 4b). After 2 weeks of incubation,
the synaptophysin staining was much more abundant in
conditioned cultures than in controls (Fig. 4c, d). Not only
were the cell bodies immunolabeled, but the reaction
product was also found along the neuronal arborizations.
Three-week-old cultures were already well developed and
equipped with synaptic contacts but comparison with
controls showed substantial differences in synaptophysin
expression (Fig. 4e, f). Figure 5 depicts the development of
the synaptic density in control cultures and OXA treated
cultures. Two-way ANOVA showed that the synaptophysin
granule density increased signiﬁcantly with age in all cul-
tures (P = 0.0005) and that the OXA conditioned networks
had a signiﬁcantly higher density of synaptophysin gran-
ules than the controls (P = 1.5 9 10
-6).
Discussion
This study demonstrates for the ﬁrst time OXA expression
in cultured dissociated cortical neurons. As is well-known,
OXA is produced only by hypothalamic neurons and cor-
tical neurons normally do not synthesize it in vivo neither
in adult nor in newborn rats (Stoyanova et al. 2010).
However, in this study, we found that isolated cortical
neurons did produce OXA, which suggests a conditioning-
related change of phenotype. The initially high level of
OXA expression decreased in the next 3–4 weeks of cul-
turing, in close synchrony to the onset and subsequent
increase of bioelectric activity.
Although neurotransmitters are generally associated
with neuronal communication in the mature brain, many of
them have been shown to inﬂuence several aspects of brain
development and maturation (Levitt et al. 1997). The
synthesis de novo of OXA in isolated neuronal cultures,
which we demonstrated here, may suggest some role for
OXA as a signaling molecule for network development as
it has been previously revealed for GABA and glutamate
(Spoerri 1988; Ben-Ari et al. 1994). The orexin system
develops very early in vivo (Van den Pol et al. 2001;
Stoyanova et al. 2010); therefore the early expression of
52 Cell Mol Neurobiol (2012) 32:49–57
123OR1 which we observed already at 1 DIV could be another
indication for the importance of orexinergic input in
developing networks. This observation is in accordance
with the ﬁndings that the human sleep disorder, narcolepsy,
as well as different neurodegenerative diseases, were
recently related to a massive reduction or deﬁcit of orexins
and their receptors and a decreased level of OXA in the
cerebrospinal ﬂuid (Cui et al. 2010; Friedman et al. 2007;
Fig. 2 a 1-Day-old culture processed for OXA detection. The
neurons are underdeveloped, and most of them exhibit OXA-IR as
dark granules, which are not dispersed in the entire cytoplasm.
b OXA expression in 1-week-old culture. IR varies from negative,
mainly in the large-sized perikarya, to highly intensive in the
medium- to small-sized neurons. c Two-week-old culture. Cells and
outgrowths are well developed. The thick arrow indicates a spindle-
shaped neuron exhibiting high intensity of OXA-staining. The double
arrow is pointing to a pyramidal perikaryon, which is OXA-negative.
d Moderate intensity of OXA-labeling of neuronal somata (arrows)i n
a 3-week-old culture. e Four-week-old culture. Two OXA-positive
multipolar neurons (arrows) with thick non-varicose processes
forming a solid network. f Histogram of the OXA expression after
subsequent DIV. Scale bars:( a, c, e)3 0lm; (b, d)5 0lm
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123Peterse ´n et al. 2005; Ripley et al. 2001). Experiments with
transient common carotid artery occlusion in mice dem-
onstrated increased levels of OXA and OR1 after ischemia
(Nakamachi et al. 2005). In addition, in orexin gene deﬁ-
cient mice permanent focal ischemia led to neuronal cell
death, clearly showing the neuroprotective role of OXA
and OR1 (Nakamachi et al. 2005).
Cortical cultures in vitro are deprived from orexinergic
input, which they normally receive in the brain in vivo. The
high expression levels of OXA suggest that cortical cul-
tures may homeostatically switch to the production of
OXA as an adaptation mechanism to the isolated envi-
ronment. A similar phenomenon has been recently descri-
bed by Corner (2008a), who showed that chronic blockade
of either NMDA or AMPA glutamate receptors in orga-
notypic neocortical slices resulted in activation of the other
receptor, which maintained spontaneous (bursting) activity
of the network. As sufﬁcient activity is vital for their sur-
vival (De Marco Garcı ´a et al. 2011), blocking both gluta-
mate receptors would eliminate all activity and cultures
would die. However, kainite receptor-mediated bursting
takes over from both of the blocked excitatory receptor-
types instead (Corner et al. 2002). When kainite receptors
were also blocked, bursts were restored partially because of
cholinergic synaptic drive, which cortical neurons normally
do not utilize (Corner 2008b). In other words, the devel-
oping network is so ﬂexible that it homeostatically
switches to another regulatory system or even to another
neuronal phenotype in order to survive.
As has been shown, the ﬁrst 2 weeks after plating are
crucial for network formation and survival (Van Pelt et al.
2004). Two major events during this period of time play a
signiﬁcant role in neuronal development: formation of
synaptically connected networks, regulated by neurotropic
and neurotrophic factors, and the emergence of bioelec-
trical network-wide activity patterns. In order to survive the
axons must have established anatomical and functional
connections by day 14 in vitro (Voigt et al. 2005). This
neuronal activity follows neural induction (in vivo) and
precedes synapse formation (Spitzer 2006). The activity
dependence of synapse formation and neuronal survival at
later stages of development has been recognized for some
Fig. 3 a Neurons cultured for 1 day expressing some IR for OR1,
mainly on the cell bodies. b Well developed neuronal network after 1
(b), 2 (c), and 4 (d) weeks in vitro. Most of the neurons express OR1,
and the reaction product is dispersed also along the neuronal
arborizations. Scale bars:( a–c)3 0lm; (d)5 0lm
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mation begins during the ﬁrst week in vitro, and reaches its
maximum around day 21 (Ichikawa et al. 1993), as does the
activity of the network (Van Pelt et al. 2004; Chiappalone
et al. 2006). This qualitatively mimics the in vivo time
course of brain development (Romijn et al. 1981), and
perfectly coincides with the appearance of the orexin-
positive structures in the brain during early postnatal stages
(Stoyanova et al. 2010), suggesting that OXA may play a
role in synaptogenesis. Indeed, the results from our
experiments with chronic application of OXA to cultured
neurons for the ﬁrst time demonstrate that OXA application
has a stimulating effect on synaptogenesis and leads to its
early onset.
Thus, in contrast to the in vivo cortex, cortical cultures
experience a complete absence of neuronal input. At early
developmental stages there is also very little internal
activity in cultured networks (see Fig. 2g). However,
Fig. 4 Immunolabeling for synaptophysin after chronic application
of OXA and in the control sister cultures at age of 4 days (a, b),
2 weeks (c, d), and 3 weeks (e, f). The OXA conditioned cultures
show a much higher expression of synaptophysin, earlier onset and
sustained increase beyond 2 weeks in vitro compared to the controls.
The panels in e and f show a closer view of fragments of
synaptophysin-positive neurons. Notice the higher synaptic density
in OXA treated culture. Scale bars:( a, b, e, f)2 0lm; (c, d)3 0lm
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OXA expression may be a homeostatic reaction to up
regulate neuronal activity in isolated cultures. This up
regulation may be twofold: OXA has a direct excitatory
effect on cortical neurons and synaptogenesis is acceler-
ated. It is yet not clear how these mechanisms interact.
Findings by van Huizen et al. suggested that synapto-
genesis may be related to network activity. They achieved
accelerated maturation in networks chronically disinhibited
by picrotoxin (van Huizen et al. 1987), whereas, classical
experiments with tetradotoxin (TTX) blockade of sponta-
neous neuronal activity in fetal rat neocortex resulted in
increased neural outgrowth and retarded synaptogenesis
(van Huizen and Romijn 1987).
Electron microscopic investigation of synaptic devel-
opment in cultured cortical cells of rats showed a decrease
in the synaptic density after 14 DIV (Ichikawa et al. 1993).
We observed a stabilization of synaptic density around that
age in the controls in our study, whereas the density of
synaptophysin expression gradually and signiﬁcantly
increased up to 21 DIV in OXA conditioned medium. The
fact that the percentage of OXA-positive neurons in our
study shows a maturational decrease over the incubation
period, reaching its plateau of 32.5% during the third week
in vitro, could be explained by a role as initial stimulator of
synaptogenesis required for establishment of functional
connections and survival of the network.
Our hypothesis that OXA is important in network for-
mation is further supported by the results of studies by Van
den Pol et al. and Li et al., who showed that orexinergic
neurons in the hypothalamus are mainly innervated by
excitatory glutamatergic synapses (Van den Pol et al. 1990,
2001), and have a unique synaptic architecture: they are
driven by glutamatergic inputs from local neurons that are
utilized by orexinergic neurons to form positive feedback
circuits onto themselves (Li et al. 2002). Thus, at the early
stages of network development, when excitatory input is
crucial (Mennerick and Zorumski 2000; De Marco Garcı ´a
et al. 2011), the neurons are able to establish regulatory
loops for self-stimulation (and thus survival) via onset of
OXA synthesis. Because of the strong mutual inﬂuences
between neuronal connectivity and activity, and the
development of connectivity, already shown at network
level (le Feber et al. 2009, 2010), further electrophysio-
logical experiments may functionally validate the effects of
OXA on the network activity.
In summary, dissociated postnatal cortical neurons of
the rat express OXA, which could be regarded as a form of
homeostatic neuronal plasticity, an adaptation mechanism
to a new environment. Our ﬁndings demonstrate for the
ﬁrst time that, in vitro, OXA stimulates synaptogenesis and
thus neuronal interactions. This implies involvement of the
neurotransmitter in network development and maturation
during the early stages of culturing. Whether this effect is
direct or exerted via different neurotrophic factors still
remains to be elucidated.
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